Mucaltin, tablets 50 mg 20 pcs

Bronchitis, colds, tracheitis, flu, chronic obstructive pulmonary disease, cough, acute and chronic respiratory diseases, accompanied by cough and formation of sputum difficult to separate high viscosity (including tracheobronchitis, obstructive bronchitis, bronchiectasis, pneumonia) – in the complex therapy.

Indications

Acute and chronic diseases of the respiratory tract, accompanied by cough and the formation of difficult to separate sputum of high viscosity (including tracheobronchitis, obstructive bronchitis, bronchiectasis, pneumonia) – as part of complex therapy.

Pharmacological effect

Pharmacotherapeutic group:

Special instructions

Impact on the ability to drive vehicles and machinery

Active ingredient

Marshmallow herb extract

Composition

Composition per tablet:

Contraindications

Hypersensitivity to the components of the drug, peptic ulcer of the stomach and duodenum, children under 12 years of age.

Side Effects

Allergic reactions, rarely – dyspepsia.

Interaction

Mucaltin can be prescribed simultaneously with other drugs used in the treatment of bronchopulmonary diseases.

Overdose

To date, no cases of overdose have been registered.

Storage conditions

Store at a temperature not exceeding 15 ºС and relative humidity not exceeding 60%.
Keep out of the reach of children.

Shelf life

2 years.

Manufacturer

Pharmstandard-Leksredstva, Russia